Navigation Links
Infant toenails reveal in utero exposure to low-level arsenic, Dartmouth study finds
Date:7/7/2014

Infant toenails are a reliable way to estimate arsenic exposure before birth, a Dartmouth College study shows.

The findings appear in the Journal of Exposure Science & Environmental Epidemiology. A PDF of the study is available on request.

A growing body of evidence suggests that in utero and early-life exposure to arsenic may have detrimental effects on children, even at the low to moderate levels common in the United States and elsewhere. The fetus starts to develop toenails during the first trimester, making them an accurate measure of exposure to arsenic during the entire gestation. Prior studies that used infant toenails as a biomarker of in utero exposure were conducted in highly exposed populations.

But in a sample of 170 motherinfant pairs from New Hampshire, the researchers determined infant exposure to relatively low arsenic in utero by evaluating infant toenails as a biomarker using plasma mass spectrometry.

The results show that a doubling of maternal postpartum toenail arsenic concentration was associated with a 54 percent increase in infant toenail arsenic concentration as compared with 20 percent for a doubling of maternal urine arsenic concentration. Also, a doubling of maternal toenail and urine arsenic concentrations was associated with a 68 percent increase in infant toenail arsenic concentration. A similar correlation between infant and maternal postpartum toenail concentrations was observed in a group of 130 motherinfant pairs from Rhode Island.

"In utero exposure to arsenic occurs through maternal drinking water and dietary sources, and infant toenails appear to be a reliable biomarker for estimating arsenic exposure during the critical window of gestation," says senior author Professor Margaret Karagas.


'/>"/>

Contact: John Cramer
John.Cramer@Dartmouth.edu
603-646-9130
Dartmouth College
Source:Eurekalert

Page: 1

Related medicine news :

1. Depressed moms behavior may play role in infants sleep problems
2. Research shows efficacy of treatment model developed at Women & Infants
3. New Techniques May Improve Infant Heart Surgery
4. Low-Income Mothers May Overfeed Their Infants
5. Gut flora affects maturation of B cells in infants
6. Phthalates in PVC floors taken up by the body in infants
7. Hazelnuts: New source of key fat for infant formula thats more like mothers milk
8. Disease that stunts infants growth traced to same gene that makes kids grow too fast
9. Infant Smarts Similar With Different Types of Formula: Study
10. Infant Vaccination Delays Triple in Oregon: Study
11. Infants cant distinguish between large and small groups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Award-winning medical group Allied Anesthesia today announced ... chair for Orange County health care system CalOptima Friday. CalOptima announced its election ... Mark Refowitz’s term, which runs through June 30 of this year, until another ...
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon ... is thrilled to offer the recently FDA-approved Obalon Balloon System to his patients. ... SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu is ...
(Date:3/28/2017)... ... , ... Oily skin is a common and unwelcomed occurrence in people of all ages, genders ... offer to the discussion of dealing with excess skin oil. “Oily skin is a challenge ... that can help remove the oily shine while keeping the skin fresh and clean,” says ...
(Date:3/27/2017)... , ... March 27, 2017 , ... New patients who ... for leading sleep apnea treatment, with or without a referral. Sleep apnea is often ... can include daytime sleepiness, morning headaches and chronic snoring. , Dr. Braasch seeks ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... Genprex, Inc. , a privately held, clinical-stage biopharmaceutical company developing immunogene ... Chief Operating Officer, is scheduled to present a corporate overview at ... Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 at 3:00 ... ... Future Leaders in Biotech Industry – Friday, April 7, 2017 at ...
(Date:3/24/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 ... of cell therapy manufacturing and focuses both on contract manufacturers ... are anticipated to emerge as viable alternatives to conventional treatment ...
Breaking Medicine Technology: